Health X Platform Limited reported a consolidated net profit of ₹198.67 lakh for the quarter ended June 30, 2026, reversing the net loss of ₹1,296.88 lakh recorded in the previous quarter. The company’s total revenue from operations grew 50% year-on-year to ₹44,684.98 lakh, up from ₹29,842.82 lakh in Q1FY25. This turnaround signals improved operational efficiency and robust demand within its core healthcare segments, despite ongoing challenges in specific subsidiaries.

The Board of Directors approved the unaudited financial results on August 07, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, J K V S & Co. Additionally, the Board approved the re-appointment of Anjana Dikshit as an Independent Director for a second term of five years, effective November 10, 2026, subject to shareholder approval.

Financial Performance Highlights

The company’s financial results for Q1FY26 reflect significant growth in top-line metrics and a return to profitability. Earnings per share (basic and diluted) stood at ₹0.80, compared to a loss per share of ₹3.51 in the prior quarter.

Standalone results showed a net loss of ₹51.43 lakh for the quarter, compared to a loss of ₹15.20 lakh in the previous quarter and ₹10.95 lakh in Q1FY25. Standalone revenue from operations remained flat at ₹8.00 lakh, primarily comprising interest income.

Segment-wise Analysis

The Healthcare Network segment remained the primary revenue driver, contributing ₹41,177.80 lakh to total revenue, a substantial increase from ₹27,853.90 lakh in Q1FY25. However, this segment reported a segment result loss of ₹1,486.95 lakh, narrowing from the ₹2,314.40 lakh loss in the prior quarter. The Financial Services segment generated ₹655.75 lakh in revenue and posted a segment profit of ₹557.18 lakh, up from a loss of ₹500.68 lakh in Q4FY26.

What the Numbers Show

The reversal to profitability in Q1FY26 was significantly aided by non-operating factors. While the Healthcare Network’s operational losses narrowed, the overall profit figure includes a tax credit of ₹48.94 lakh against current tax expenses of ₹47.75 lakh. Furthermore, the ‘Others’ segment contributed ₹2,851.43 lakh in revenue with a profit of ₹54.82 lakh, indicating diversification efforts are yielding returns. However, investors should note that the standalone entity continues to incur losses, highlighting that the group-level profitability is currently sustained by its subsidiaries’ performance rather than the holding company’s core operations.

Corporate Developments and Disclosures

The Board had previously approved a Composite Scheme of Arrangement and Amalgamation involving Health X Platform Limited, Microsec Resources Private Limited, Innogrow Technologies Limited, and Sastasundar Healthbuddy Limited, with an appointed date of April 01, 2026. No accounting effect has been given in the Q1FY26 results pending requisite approvals. The company incurred ₹14.75 lakh in expenses related to this scheme during the quarter.

Statutory auditors J K V S & Co highlighted a material uncertainty regarding the going concern status of step-down subsidiary Genu Path Labs Limited (GPLL). GPLL’s net worth has completely eroded, and its current liabilities exceed current assets. Despite this, GPLL’s financials have been prepared on a going concern basis, supported by assurances of continued financial support from Sastasundar Healthbuddy Limited.

Health X Platform Limited will host an earnings conference call on Tuesday, August 11, 2026, at 4:00 PM IST to discuss its financial performance and business updates for the first quarter of FY27 (Q1FY27). The session provides investors and analysts with a direct channel to management regarding the company’s results for the quarter ended June 30, 2026.

The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Health X Platform Limited, formerly known as Sastasundar Ventures Limited, submitted the intimation to the BSE Limited and The National Stock Exchange of India Ltd. on August 5, 2026. The company emphasized that only information available in the public domain will be shared during the interaction, ensuring no unpublished price-sensitive information is disclosed.

Key Participants and Host

The conference call is hosted by Go India Advisors. The following senior executives are confirmed to participate in the discussion:

Call Access and Registration

Investors and analysts must pre-register to receive login details for the virtual session. The company has provided universal dial-in numbers for those preferring audio access via telephone. The schedule is subject to change due to exigencies on the part of the analysts or investors.

For further assistance, participants may contact Sheetal Khanduja or Soumya Chhajer at Go India Advisors. The company’s registered office is located at Azimganj House, Kolkata, and it operates under the Scrip Code 533259 on BSE and Symbol HEALTHX on NSE.